A taRNA vaccine candidate induces a specific immune response that protects mice against Chikungunya virus infections
C Schmidt, E Haefner, J Gerbeth, T Beissert… - … Therapy-Nucleic Acids, 2022 - cell.com
The arthritogenic alphavirus, chikungunya virus (CHIKV), is now present in almost 100
countries worldwide. Further spread is very likely, which raises public health concerns …
countries worldwide. Further spread is very likely, which raises public health concerns …
A bivalent trans-amplifying RNA vaccine candidate induces potent chikungunya and ross river virus specific immune responses
C Schmidt, FD Hastert, J Gerbeth, T Beissert, U Sahin… - Vaccines, 2022 - mdpi.com
Alphaviruses such as the human pathogenic chikungunya virus (CHIKV) and Ross River
virus (RRV) can cause explosive outbreaks raising public health concerns. However, no …
virus (RRV) can cause explosive outbreaks raising public health concerns. However, no …
Chikungunya virus antepartum transmission and abnormal infant outcomes in Nigeria
AS Sagay, SC Hsieh, YC Dai, CA Chang, J Ogwuche… - medRxiv, 2023 - medrxiv.org
Chikungunya virus (CHIKV) has become a global public health concern since the
reemergence of the Indian Ocean lineage and expansion of the Asian genotype. CHIKV …
reemergence of the Indian Ocean lineage and expansion of the Asian genotype. CHIKV …
Development of a Novel Chikungunya Virus-Like Replicon Particle for Rapid Quantification and Screening of Neutralizing Antibodies and Antivirals
HC Lin, DJ Chiao, PY Shu, HT Lin… - Microbiology …, 2023 - Am Soc Microbiol
Chikungunya fever is a mosquito-transmitted infectious disease that induces rash, myalgia,
and persistent incapacitating arthralgia. At present, no vaccines or antiviral therapies …
and persistent incapacitating arthralgia. At present, no vaccines or antiviral therapies …